IMTXW NASDAQ
immatics biotechnologies GmbH
1W: -92.1%
1M: -96.4%
3M: -98.8%
1Y: -100.0%
3Y: -100.0%
$0.00
Last traded 2025-06-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$562M
-19.3% ▼
5Y CAGR: +17.2%
Total Liabilities
$78M
-35.5% ▼
5Y CAGR: -12.3%
Shareholders Equity
$484M
-15.8% ▼
5Y CAGR: +35.9%
Cash & Investments
$469M
-22.4% ▼
5Y CAGR: +15.1%
Total Debt
$16M
-3.5% ▼
5Y CAGR: +20.4%
Net Debt
-$330M
-49.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $133M | $149M | $218M | $237M | $346M |
| Short-Term Investments | $12M | $214M | $207M | $368M | $123M |
| Cash & ST Investments | $145M | $362M | $426M | $604M | $469M |
| Net Receivables | $2M | $1M | $6M | $7M | $7M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $950K | $14M | $7M | $6M | $15M |
| Total Current Assets | $152M | $377M | $449M | $630M | $504M |
| Property, Plant & Equip. | $20M | $26M | $57M | $64M | $55M |
| Goodwill & Intangibles | $1M | $2M | $2M | $2M | $2M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $636K | $3M | $2M | $1M | $2M |
| Total Non-Current Assets | $22M | $31M | $61M | $67M | $58M |
| Total Assets | $175M | $408M | $510M | $696M | $562M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $4M | $8M | $10M | $340K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $3M |
| Deferred Revenue | $50M | $65M | $100M | $36M | $16M |
| Other Current Liabilities | $28M | $18M | $20M | $5M | $22M |
| Total Current Liabilities | $95M | $106M | $157M | $68M | $43M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $48M | $42K | $116M | $0 | $0 |
| Total Non-Current Liabilities | $55M | $88M | $128M | $53M | $35M |
| Total Liabilities | $151M | $195M | $285M | $121M | $78M |
| — Equity — | |||||
| Common Stock | $629K | $767K | $847K | $1M | $1M |
| Retained Earnings | -$538M | -$500M | -$597M | -$590M | -$786M |
| Accumulated OCI | -$4M | -$1M | -$2M | $1M | -$9M |
| Total Stockholders Equity | $24M | $213M | $225M | $575M | $484M |
| Total Liabilities & Equity | $175M | $408M | $510M | $696M | $562M |
| — Key Metrics — | |||||
| Total Debt | $10M | $15M | $15M | $16M | $16M |
| Net Debt | -$123M | -$134M | -$203M | -$221M | -$330M |
| Total Investments | $12M | $214M | $207M | $368M | $123M |